FDA Follow-On Biologics Guidance Will Follow Public Workshop, Agency Tells Senate Committee

A public scientific workshop is planned for late summer; timing or content of a guidance cannot be predicted until after the meeting, Acting Commissioner Crawford tells Senate Judiciary Committee. Sen. Schumer expresses concern that progress towards "generic" biologics is "slowing."